Neuraxial Labor Analgesia and the Incidence of Postpartum Depression

July 19, 2021 updated by: Dong-Xin Wang, Peking University First Hospital

Impact of Neuraxial Labor Analgesia on the Incidence of Postpartum Depression: a Prospective, Observational, Multicenter Cohort Study

Postpartum depression (PPD) affects approximately 15% of women during the first year after giving birth, and is common across cultures. The etiology of postpartum depression is not totally clear. The severe pain experienced during childbirth was reported to be associated with the development of postpartum depression. The purpose of the present study is to evaluate whether use of neuraxial labor analgesia can reduce the incidence of postpartum depression.

Study Overview

Detailed Description

Postpartum depression (PPD) affects approximately 15% of women during the first year after giving birth, and is common across cultures. In postpartum Chinese women, the reported incidence ranged from 6.5% to 29.5%.

The etiology of postpartum depression is not totally clear. Identified risk factors include previous maternal blues, unplanned pregnancy, lack of marital or social support, and previous psychiatric illnesses. Furthermore, the severe pain experienced during childbirth was reported to be associated with the occurrence of postpartum depression.

A recent study of the investigators found that use of epidural analgesia during labor was associated with decreased risk of postpartum depression. However, several limitations existed in that study and further evidence is needed to reconfirm the finding. The purpose of the present study is to reevaluate whether use of neuraxial labor analgesia can reduce the incidence of postpartum depression.

Study Type

Observational

Enrollment (Actual)

599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 34 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Primiparae between 18 and 34 years of age with term single cephalic pregnancy who are preparing to deliver vaginally during the daytime hours.

Description

Inclusion Criteria:

  1. Primiparae between 18 and 34 years of age with term single cephalic pregnancy;
  2. Admitted to the delivery room during daytime working hours (from 8 am to 5 pm).
  3. Preparing to deliver vaginally.

Exclusion Criteria:

  1. History of psychiatric disease (indicate those that are diagnosed before or during pregnancy by psychiatrists);
  2. Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.
  3. Other reasons that are considered unsuitable for study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
No neuraxial labor analgesia
For patients who do not accept neuraxial labor analgesia, analgesics will be prescribed by obstetricians according to routine practice.
Neuraxial analgesia will not be performed. Analgesics will be prescribed by the obstetricians according to routine practice.
Neuraxial labor analgesia
For patients who accept neuraxial labor analgesia, epidural analgesia or combined spinal-epidural analgesia will be provided when the cervix is dilated to 1 cm or more and continued until the cervix is fully dilated to 10 cm.
Epidural or combined spinal-epidural labor analgesia will be performed when the cervix is dilated to 1 cm or more and continued until the cervix is fully dilated to 10 cm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of postpartum depression
Time Frame: At 42 days after delivery
Postpartum depression will be defined by a score of 10 or more on the Edinburgh Postnatal Depression Scale.
At 42 days after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The mode of delivery
Time Frame: At the time of delivery
The mode of delivery includes spontaneous delivery, instrumental delivery, and Caesarean delivery.
At the time of delivery
Neonatal Apgar score
Time Frame: At 1 and 5 minutes after delivery
The Apgar score ranges from 0 to 10, with higher score indicating a better outcome. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts.
At 1 and 5 minutes after delivery
Status of baby feeding
Time Frame: At 24 hours and 42 days after delivery
The mode of baby feeding include breast feeding, mixed feeding, and formula feeding.
At 24 hours and 42 days after delivery
Severity of pain
Time Frame: At 24 hours and 42 days after delivery
Severity of pain is evaluated with Numeric Rating Scale (NRS), where 0 indicates no pain and 10 the most severe pain.
At 24 hours and 42 days after delivery
Persistent pain
Time Frame: At 42 days after delivery
Persistence pain is defined as a NRS pain score ≥1 that persisted since childbirth.
At 42 days after delivery
Persistent pain affecting daily life
Time Frame: At 42 days after delivery
One of the following activities (including walking, mood, sleep or concentration) is affected by persistent pain, as judged by parturients themselves.
At 42 days after delivery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
2-year depression
Time Frame: Assessed between 23 to 24 months after childbirth.
2-year depression is assessed with the Edinburgh Postnatal Depression Scale, a score of 10 or higher is defined as the presence of depression.
Assessed between 23 to 24 months after childbirth.
Degree of social support
Time Frame: Assessed between 23 to 24 months after childbirth.
Degree of social support is assessed with the Social Support Rating Scale, score range 11 to 62, with higher score indicating better social support.
Assessed between 23 to 24 months after childbirth.
Maternal body weight
Time Frame: Assessed between 23 to 24 months after childbirth.
Maternal body weight
Assessed between 23 to 24 months after childbirth.
Maternal height
Time Frame: Assessed between 23 to 24 months after childbirth.
Maternal height
Assessed between 23 to 24 months after childbirth.
Duration of breast-feeding
Time Frame: Up to 24 months after childbirth.
Duration of breast-feeding
Up to 24 months after childbirth.
Start of complementary feeding
Time Frame: Up to 24 months after childbirth.
Start of complementary feeding
Up to 24 months after childbirth.
Chronic pain after childbirth
Time Frame: Up to 24 months after childbirth.
Defined as persistent or recurrent pain that lasted for more than 3 months after childbirth.
Up to 24 months after childbirth.
Chronic pain affecting daily life
Time Frame: Up to 24 months after childbirth.
Defined as chronic pain that interfered daily life activities including walking, mood, sleep or concentration, as judged by parturients themselves.
Up to 24 months after childbirth.
Maternal disease after childbirth
Time Frame: Up to 24 months after childbirth
Refer to any new-onset disease that occurs after childbirth and requires medical therapy or surgical procedures.
Up to 24 months after childbirth
Another childbirth
Time Frame: Up to 24 months after the first childbirth.
Another childbirth
Up to 24 months after the first childbirth.
Mental Development Index
Time Frame: Assessed between 23 to 24 months of age.
Assessed with the Mental Scale subtest of the Bayley Scales of Infant Development-Chinese Revision. The subtest includes 163 items and assesses adaptive behavior, language and cognitive ability. The raw score of successfully completed items is converted to the standardized Mental Development Index. The average score of Mental Development Index in normal urban children is 100 with a SD of 15, with higher score indicating better development.
Assessed between 23 to 24 months of age.
Psychomotor Development Index
Time Frame: Assessed between 23 to 24 months of age.
Assessed with the Motor Scale subtest of the Bayley Scales of Infant Development-Chinese Revision. The subtest includes 81 items and assesses gross and fine motor skills. The raw score of successfully completed items is converted to the standardized Psychomotor Development Index. The average score of Psychomotor Development Index in normal urban children is 100 with a SD of 15, with higher score indicating better development.
Assessed between 23 to 24 months of age.
Child body weight
Time Frame: Assessed between 23 to 24 months of age.
Child body weight
Assessed between 23 to 24 months of age.
Child height
Time Frame: Assessed between 23 to 24 months of age.
Child height
Assessed between 23 to 24 months of age.
Pediatric disease
Time Frame: Up to 24 months of age.
Indicates any congenital or acquired disease that requires medical therapy or surgical procedures.
Up to 24 months of age.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2014

Primary Completion (ACTUAL)

May 29, 2015

Study Completion (ACTUAL)

April 25, 2017

Study Registration Dates

First Submitted

June 28, 2016

First Submitted That Met QC Criteria

June 30, 2016

First Posted (ESTIMATE)

July 6, 2016

Study Record Updates

Last Update Posted (ACTUAL)

July 26, 2021

Last Update Submitted That Met QC Criteria

July 19, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2014[712]
  • ChiCTR-OCH-14004888 (REGISTRY: Chinese Clinical Trial Registry (www.chictr.org.cn))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression, Postpartum

Clinical Trials on No neuraxial labor analgesia

Subscribe